ABC
SAGE

Associated Banc-Corp’s Sage Therapeutics SAGE Stock Holding History

Associated Banc-Corp’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-18
Closed -$2K – 757
2020
Q4 		$2K Hold
18
– – ﹤0.01% 832
2020
Q3 		$1K Sell
18
-15
-45% -$760 ﹤0.01% 925
2020
Q2 		$1K Sell
33
-14
-30% -$508 ﹤0.01% 890
2020
Q1 		$1K Buy
+47
New +$2.72K ﹤0.01% 848

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Associated Banc-Corp's SAGE Position: Q1 2021 in Review

Associated Banc-Corp sold out of Sage Therapeutics (SAGE) in Q1 2021, closing a stake of 18 shares — an estimated $2K sold.

Associated Banc-Corp first reported a position in SAGE in Q1 2020 and held it in 4 quarters. The position peaked at $2K in Q4 2020. 263 funds tracked by Wall St. Rank hold SAGE as of Q1 2021.

  • Associated Banc-Corp reported no remaining Sage Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Associated Banc-Corp sold 18 Sage Therapeutics shares in Q1 2021, an estimated $2K.
  • Associated Banc-Corp first reported a position in Sage Therapeutics in Q1 2020 and held it in 4 quarters.
  • Associated Banc-Corp's Sage Therapeutics position peaked at $2K in Q4 2020.
  • 263 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.